NovoCure Ltd - Ordinary Shares, no par value per share (NVCR)

CUSIP: G6674U108

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Ordinary Shares, no par value per share
Shares outstanding
112,245,592
Total 13F shares
92,292,343
Share change
+1,716,086
Total reported value
$1,490,614,876
Put/Call ratio
77%
Price per share
$16.15
Number of holders
219
Value change
-$68,391,278
Number of buys
112
Number of sells
140

Quarterly Holders Quick Answers

What is CUSIP G6674U108?
CUSIP G6674U108 identifies NVCR - NovoCure Ltd - Ordinary Shares, no par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NovoCure Ltd - Ordinary Shares, no par value per share (NVCR) as of Q3 2023

As of 30 Sep 2023, NovoCure Ltd - Ordinary Shares, no par value per share (NVCR) was held by 219 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 92,292,343 shares. The largest 10 holders included FMR LLC, VANGUARD GROUP INC, Capital International Investors, Capital World Investors, BlackRock Inc., BAILLIE GIFFORD & CO, Deep Track Capital, LP, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, and VOLORIDGE INVESTMENT MANAGEMENT, LLC. This page lists 219 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.